GLP-1RAs may offer modest antidepressant effects compared to DPP4is but not SGLT-2is: Study Dr. Kamal Kant Kohli25 Feb 2025 10:45 PM ISTA target trial emulation study compared risk for depression among older adults with type 2 diabetes initiating treatment with glucagon-like peptide-1...
Comparative Effectiveness of SGLT-2 Inhibitors: Low-Dose Dapagliflozin Falls Short in Heart Failure Prevention, Study Medha Baranwal24 Jan 2025 9:00 AM ISTUSA: A recent study published in JAMA Internal Medicine has evaluated the comparative effectiveness of individual sodium-glucose cotransporter 2...
Add on SGLT-2 Inhibitors may help manage recurrence of nephrolithiasis and Gout in kidney stone patients, suggests study Medha Baranwal6 Nov 2024 3:30 AM ISTUSA: A recent study has shed light on the potential advantages of sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients experiencing...
SGLT2 Inhibitors may Cut Risk of Arrhythmias and Cardiac Arrest in High-Risk Patients, Study Finds Medha Baranwal2 Aug 2024 9:45 AM ISTCHINA: In a recent systematic review and meta-analysis of cardiovascular outcome trials, SGLT2 inhibitors significantly reduce the risk of various...
SGLT2 Inhibitors Significantly Improve Kidney and Cardiac outcomes in SLE Patients with Type 2 Diabetes: JAMA Medha Baranwal30 July 2024 9:15 AM ISTTaiwan: A recent study has revealed improved kidney and cardiac outcomes using sodium-glucose cotransporter-2 (SGLT2) inhibitors for patients with...
Hyperkalemia and hypokalemia consistently reported less frequently with SGLT2i compared to other antidiabetics: Study Medha Baranwal13 July 2024 9:00 AM ISTChina: In real-world scenarios, SGLT-2 inhibitors showed lower and more consistent reports of hyperkalemia and hypokalemia compared to other diabetes...
SGLT2 inhibitors improve kidney and cardiac outcomes in patients with SLE and type 2 diabetes: JAMA Medha Baranwal14 Jun 2024 9:15 AM ISTTaiwan: In a significant stride towards understanding and potentially managing nephritis in patients with systemic lupus erythematosus (SLE), a recent...
Unveiling Other Side of coin: linking SGLT2 Inhibitors to Euglycemic Diabetic Ketoacidosis Medha Baranwal25 May 2024 10:00 AM ISTIndia: In a startling revelation, a recent case study has brought to light an uncommon yet potentially life-threatening complication associated with...
Among diabetes patients, SGLT2 inhibitors less likely to cause gout compared to sulfonylureas: JAMA Medha Baranwal20 April 2024 10:00 AM ISTUSA: The use of SGLT2 inhibitors versus sulfonylureas was associated with a lower risk of incident gout, heart failure (HF), and major adverse...
MR Study sheds light on anti-inflammatory effects of SGLT-2 inhibitors and their beneficial impact in reducing HF risk Medha Baranwal10 April 2024 10:00 AM ISTChina: A two-sample Mendelian randomization (MR) study provides genetic evidence supporting the anti-inflammatory effects of sodium-glucose...
Dapagliflozin leads to modest reduction in systolic BP in patients with CKD and albuminuria: Study Medha Baranwal21 Feb 2024 3:00 AM ISTUSA: Treatment with dapagliflozin in patients with chronic kidney disease (CKD) and albuminuria is associated with modest but clinically meaningful...
Study reveals additive effects of SGLT2i and GLP-1RA in enhancing vascular repair among patients with diabetes and obesity Medha Baranwal21 Feb 2024 12:30 AM ISTCanada: A recent study published in Cardiovascular Research has shed light on restoring blood vessel regeneration in the era of the combination of...
